A new version (2 July 2026) of the guidance on coding indications in the XEVMPD has been published.

T1, T2, T3

PrevPreviousA new version (June 2026) of the “MDCG Position Paper: Management of the Summary of Safety and Performance in Eudamed after Mandatory Use” has been published.

NextA new version (6 July 2026) of the ‘User manual for the extended EudraVigilance Medicinal Product Dictionary (XEVMPD) user interface (XEVMPDweb)’ has been publishedNext

Pamplona

imunify-bot-check

GDPR Cookie Banner

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in .

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

Enabled Disabled

Marketing

This website uses the following additional cookies:

(List the cookies that you are using on the website here.)

Enabled Disabled

Cookie Policy

More information about our Cookie Policy

A new version (2 July 2026) of the guidance on coding indications in the XEVMPD has been published.

Zaragoza

Pamplona